Novartis

Acquires certain oncology products and pipeline compounds from GSK

Fortune magazine has announced its list of 2015 'World’s Most Admired Companies.' The companies on the world’s most admired list…

Net sales of the pharmaceuticals business grew by 1.2 per cent during the quarter ended December 31, 2014

During the quarter under review, profit before tax was Rs 4.4 crore as against Rs 21.6 crore in the previous corresponding period…

Oncology, autoimmune and infectious diseases/vaccines are areas for novel therapeutics and in vitro diagnostics in 2015

Cosentyx is the only biologic that can be used as first-line systemic therapy in the treatment of psoriasis and as an alternative…

Novartis has approved the sale of its OTC Division to GlaxoSmithKline Consumer for Rs 1097.3 million. It may be noted that as part…

To explore making medicines and drug discovery tools with CRISPR genome editing technology

The completion of this transaction will focus Novartis on its three leading businesses of global scale: innovative…

First interleukin-17A inhibitor to get Japanese nod for either indication